UK IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

CHAPTER 1 INTRODUCTION

1.1 REPORT DESCRIPTION

1.2 KEY BENEFITS

1.3 KEY MARKET SEGMENTS

1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research

1.4.2 Primary research

1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE

3.2 KEY FINDINGS

3.2.1 Top investment pockets

3.2.2 Top winning strategies

3.3 PORTERS FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers

3.3.2 Bargaining power of buyers

3.3.3 Threat of new entrants

3.3.4 Threat of substitute

3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016

3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases

3.5.1.2 Technological advancements in IVD

3.5.1.3 Emergence of minimal invasive technologies

3.5.1.4 Increasing government expenditures on healthcare

3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies

3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing

3.5.3.2 Convergence of new technologies

CHAPTER 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends

4.2.2 Key growth factors and opportunities

4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends

4.3.2 Key growth factors and opportunities

4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends

4.4.2 Key growth factors and opportunities

4.4.3 Market size and forecast

CHAPTER 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends

5.2.2 Key growth factors and opportunities

5.2.3 Market size and forecast

5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast

5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends

5.3.2 Key growth factors and opportunities

5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends

5.4.2 Key growth factors and opportunities

5.4.3 Market size and forecast

5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends

5.5.2 Key growth factors and opportunities

5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends

5.6.2 Key growth factors and opportunities

5.6.3 Market size and forecast

5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends

5.7.2 Key growth factors and opportunities

5.7.3 Market size and forecast

CHAPTER 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends

6.1.2 Key growth factors and opportunities

6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends

6.2.2 Key growth factors and opportunities

6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends

6.3.2 Key growth factors and opportunities

6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends

6.4.2 Key growth factors and opportunities

6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends

6.5.2 Key growth factors and opportunities

6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends

6.6.2 Key growth factors and opportunities

6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends

6.7.2 Key growth factors and opportunities

6.7.3 Market size and forecast

CHAPTER 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends

7.2.2 Key growth factors and opportunities

7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends

7.3.2 Key growth factors and opportunities

7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends

7.4.2 Key growth factors and opportunities

7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends

7.5.2 Key growth factors and opportunities

7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 THERMO FISHER SCIENTIFIC INC.

8.1.1 Company overview

8.1.2 Business performance

8.1.3 Key strategies and development

8.2 ALERE INC.

8.2.1 Company overview

8.2.2 Business performance

8.2.3 Key strategies and developments

8.3 BIOMERIEUX

8.3.1 Company overview

8.3.2 Business performance

8.3.3 Key strategies and developments

8.4 DANAHER CORPORATION

8.4.1 Company overview

8.4.2 Business performance

8.4.3 Key strategies and development

8.5 F. HOFFMANN-LA ROCHE AG

8.5.1 Company overview

8.5.2 Business performance

8.5.3 Key strategies and developments

8.6 BECTON DICKINSON AND COMPANY

8.6.1 Company overview

8.6.2 Business performance

8.6.3 Key strategies and development

8.7 BIO-RAD LABORATORIES

8.7.1 Company overview

8.7.2 Business performance

8.7.3 Key strategies and developments

8.8 BAYER AG

8.8.1 Company overview

8.8.2 Business performance

8.8.3 Key strategies and development

8.9 SYSMEX CORPORATION

8.9.1 Company overview

8.9.2 Business performance

8.9.3 Key strategies and developments

8.10 JOHNSON & JOHNSON

8.10.1 Company overview

8.10.2 Business performance

8.10.3 Key strategies and development

List of Figures

FIGURE 1 MARKET SEGMENTATION

FIGURE 2 TOP INVESTMENT POCKETS

FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)

FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016

FIGURE 5 PORTERS FIVE FORCES ANALYSIS

FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016

FIGURE 7 UK CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)

FIGURE 8 UK FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)

FIGURE 9 UK COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)

FIGURE 10 UK RAPID TESTS MARKET, 2016-2023 ($MILLION)

FIGURE 11 UK ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)

FIGURE 12 UK RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)

FIGURE 13 UK WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)

FIGURE 14 UK POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)

FIGURE 15 UK ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)

FIGURE 16 UK HYBRIDIZATION MARKET, 2016-2023 ($MILLION)

FIGURE 17 UK DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)

FIGURE 18 UK MICROARRAY MARKET, 2016-2023 ($MILLION)

FIGURE 19 UK OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)

FIGURE 20 UK BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)

FIGURE 21 UK LIVER PANEL MARKET, 2016-2023 ($MILLION)

FIGURE 22 UK RENAL PROFILE MARKET, 2016-2023 ($MILLION)

FIGURE 23 UK LIPID PROFILE MARKET, 2016-2023 ($MILLION)

FIGURE 24 UK THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)

FIGURE 25 UK ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)

FIGURE 26 UK SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)

FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)

FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)

FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)

FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)

FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)

FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)

FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)

FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)

FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)

FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)

FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)

FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)

FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)

FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)

List of Tables

TABLE 1 INCIDENCE OF DISEASES

TABLE 2 UK IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)

TABLE 3 UK IVD REAGENTS MARKET, 2016-2023 ($MILLION)

TABLE 4 UK IVD INSTRUMENTS MARKET, 2016-2023 ($MILLION)

TABLE 5 UK IVD SOFTWARE & SERVICES MARKET, 2016-2023 ($MILLION)

TABLE 6 UK IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)

TABLE 7 UK IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)

TABLE 8 UK IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)

TABLE 9 UK IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)

TABLE 10 UK IVD BLOOD TESTING TECHNIQUE MARKET, 2016-2023 ($MILLION)

TABLE 11 UK IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 12 UK IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, 2016-2023 ($MILLION)

TABLE 13 UK IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2016-2023, ($MILLION)

TABLE 14 UK IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, 2016-2023 ($MILLION)

TABLE 15 UK OTHER IVD TECHNIQUES MARKET, 2016-2023, ($MILLION)

TABLE 16 UK IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)

TABLE 17 UK IVD INFECTIOUS DISEASES MARKET, 2016-2023 ($MILLION)

TABLE 18 UK IVD CANCER MARKET, 2016-2023 ($MILLION)

TABLE 19 UK IVD CARDIAC DISEASES MARKET, 2016-2023 ($MILLION)

TABLE 20 UK IVD IMMUNE SYSTEM DISORDER MARKET, 2016-2023 ($MILLION)

TABLE 21 UK IVD NEPHROLOGICAL DISEASES MARKET, 2016-2023, ($MILLION)

TABLE 22 UK IVD GASTROINTESTINAL DISEASES MARKET, 2016-2023 ($MILLION)

TABLE 23 UK IVD OTHER INDICATION MARKET, 2016-2023 ($MILLION)

TABLE 24 UK IVD MARKET, BY END USER, 2016-2023, ($MILLION)

TABLE 25 UK IVD STANDALONE LABORATORIES MARKET, 2016-2023 ($MILLION)

TABLE 26 UK IVD HOSPITALS MARKET, 2016-2023 ($MILLION)

TABLE 27 UK IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, 2016-2023 ($MILLION)

TABLE 28 UK IVD POINT OF CARE MARKET, 2016-2023 ($MILLION)

TABLE 29 UK IVD OTHER END-USER MARKET, 2016-2023 ($MILLION)

TABLE 30 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT

TABLE 31 ALERE INC. COMPANY SNAPSHOT

TABLE 32 BIOMERIEUX COMPANY SNAPSHOT

TABLE 33 DANAHER CORPORATION COMPANY SNAPSHOT

TABLE 34 ROCHE DIAGNOSTICS COMPANY SNAPSHOT

TABLE 35 BECTON DICKINSON AND COMPANY SNAPSHOT

TABLE 36 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT

TABLE 37 BAYER AG COMPANY SNAPSHOT

TABLE 38 SYSMEX CORPORATION COMPANY SNAPSHOT

TABLE 39 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT